Advertisement
Research Article| Volume 50, ISSUE 8, P736-738, December 2012

Download started.

Ok

Trans-mastoid facial nerve localisation for malignant neoplasms confined to the parotid gland

  • Nazia Munir
    Correspondence
    Corresponding author. Tel.: +44 1515295262.
    Affiliations
    Department of Otorhinolaryngology, Head and Neck Surgery, Aintree University Hospitals NHS Foundation Trust, Lower Lane, Liverpool, Merseyside L9 7AL, United Kingdom
    Search for articles by this author
  • Sankalap Tandon
    Affiliations
    Department of Otorhinolaryngology, Head and Neck Surgery, Aintree University Hospitals NHS Foundation Trust, Lower Lane, Liverpool, Merseyside L9 7AL, United Kingdom
    Search for articles by this author
  • James S. Brown
    Affiliations
    Department of Maxillofacial & Head and Neck Surgery, Aintree University Hospitals NHS Foundation Trust, Lower Lane, Liverpool, Merseyside L9 7AL, United Kingdom
    Search for articles by this author
  • Tristram H.J. Lesser
    Affiliations
    Department of Otorhinolaryngology, Head and Neck Surgery, Aintree University Hospitals NHS Foundation Trust, Lower Lane, Liverpool, Merseyside L9 7AL, United Kingdom
    Search for articles by this author
Published:January 04, 2012DOI:https://doi.org/10.1016/j.bjoms.2011.12.002

      Abstract

      Up to 32% of parotid neoplasms are malignant, and treatment for resectable parotid carcinomas remains primarily surgical. Resection is centred round the identification and preservation (where possible) of the main trunk of the facial nerve. Limited dissection of the temporal bone and identification of the facial nerve proximally in the mastoid portion can facilitate resection for all parotid carcinomas that occur in the preauricular portion of the gland. Dissection in the narrow space between the ear or base of the skull and the tumour reduces the risk of tumour spillage, and the margin for resection is optimised. Intramastoid localisation of the facial nerve allows a posterior approach, and access to the dissection plane lies medial to the nerve. We describe the technique in a series of eight patients undergoing resection for parotid malignancies. In our experience the technique promotes adequate resection margins, reduces the risk of tumour spillage, and allows better access for nerve grafting if the facial nerve has to be sacrificed.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dorairajan N.
        • Periyasamy S.
        • Muthayya P.
        • Manikandan R.
        • Srinivasan T.
        • Siddharth D.
        Salivary gland tumors: a 10-year retrospective study of survival in relation to size, histopathological examination of the tumor, and nodal status.
        Int Surg. 2004; 89: 140-149
        • Guzzo M.
        • Locati L.D.
        • Prott F.J.
        • Gatta G.
        • McGurk M.
        • Licitra L.
        Major and minor salivary gland tumors.
        Crit Rev Oncol Hematol. 2010; 74: 134-148
        • Nagliati M.
        • Bolner A.
        • Vanoni V.
        • Tomio L.
        • Lay G.
        • Murtas R.
        • et al.
        Surgery and radiotherapy in the treatment of malignant parotid tumors: a retrospective multicenter study.
        Tumori. 2009; 95: 442-448
        • Laccourreye H.
        • Laccourreye O.
        • Cauchois R.
        • Jouffre V.
        • Ménard M.
        • Brasnu D.
        Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients.
        Laryngoscope. 1994; 104: 1487-1494
        • Sargi Z.
        • Gerring R.
        • Angeli S.
        • Arnold D.
        • Eshraghi A.
        • Civantos F.
        • et al.
        Parotid and temporal bone resection for skull base malignancies: outcome.
        Skull Base. 2010; 20: 169-177
      1. Cancer incidence in five continents. vol. VIII, no. 155. IARC Scientific Publications, Lyon2002
        • Spiro J.D.
        • Spiro R.H.
        Cancer of the parotid gland: role of 7th nerve preservation.
        World J Surg. 2003; 27: 863-867
        • Jeannon J.P.
        • Calman F.
        • Gleeson M.
        • McGurk M.
        • Morgan P.
        • O’Connell M.
        • et al.
        Management of advanced parotid cancer. A systematic review.
        Eur J Surg Oncol. 2009; 35: 908-915
        • Huang C.C.
        • Tseng F.Y.
        • Chen Z.C.
        • Hsu C.J.
        • Ko J.Y.
        • Lou P.J.
        • et al.
        Malignant parotid tumor and facial palsy.
        Otolaryngol Head Neck Surg. 2007; 136: 778-782
        • De Vincentiis M.
        • Magliulo G.
        • Soldo P.
        • Manciocco V.
        • Pagliuca G.
        • Del Gaizo R.
        • et al.
        Extended parotidectomy.
        Acta Otorhinolaryngol Ital. 2005; 25: 169-173